TP53 and cancer: To check if the gained and lost peaks overlap with the regulatory regions (such as enhancer and histone marks), we overlapped these peaks with the enhancer predictions (from GeneHancer [25]) as well as available histone marks (such as H3K27ac associated with enhancer regions) from cancer cell-lines harbouring gain-of-function mutant p53 (see Methods).